Total Payments
$1,271
2024 Payments
$221.28
Companies
11
Transactions
43
Medicare Patients
2,829
Medicare Billing
$336,541
Payment Breakdown by Category
Food & Beverage$1,051 (82.7%)
Gifts$179.95 (14.2%)
Education$39.56 (3.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,051 | 39 | 82.7% |
| Gift | $179.95 | 3 | 14.2% |
| Education | $39.56 | 1 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $407.54 | 23 | $0 (2024) |
| Endogastric Solutions, Inc | $338.28 | 7 | $0 (2023) |
| Braintree Laboratories, Inc. | $179.95 | 3 | $0 (2021) |
| Phathom Pharmaceuticals, Inc. | $103.25 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $99.80 | 1 | $0 (2019) |
| UCB, Inc. | $41.87 | 3 | $0 (2019) |
| Madrigal Pharmaceuticals | $39.56 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.69 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $13.87 | 1 | $0 (2024) |
| AbbVie, Inc. | $13.09 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $221.28 | 6 | Phathom Pharmaceuticals, Inc. ($103.25) |
| 2023 | $367.55 | 12 | Janssen Biotech, Inc. ($194.80) |
| 2022 | $194.84 | 13 | Janssen Biotech, Inc. ($156.93) |
| 2021 | $86.21 | 2 | Braintree Laboratories, Inc. ($73.31) |
| 2020 | $14.19 | 1 | Endogastric Solutions, Inc ($14.19) |
| 2019 | $336.87 | 5 | Endogastric Solutions, Inc ($113.43) |
| 2017 | $49.69 | 4 | UCB, Inc. ($24.87) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/17/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Immunology | ||||||
| 05/24/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Immunology | ||||||
| 05/17/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Immunology | ||||||
| 05/05/2022 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $13.04 | General |
| Category: GERD | ||||||
| 02/11/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Immunology | ||||||
| 02/01/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: Immunology | ||||||
| 06/25/2021 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Immunology | ||||||
| 02/26/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Gift | Cash or cash equivalent | $73.31 | General |
| Category: GI COLON PREP | ||||||
| 03/12/2020 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: GERD | ||||||
| 08/23/2019 | Braintree Laboratories, Inc. | SUPREP BOWEL PREP (Drug) | Gift | In-kind items and services | $53.32 | General |
| Category: GI COLON PREP | ||||||
| 06/25/2019 | Braintree Laboratories, Inc. | SUPREP BOWEL PREP (Drug) | Gift | In-kind items and services | $53.32 | General |
| Category: GI COLON PREP | ||||||
| 06/19/2019 | Endogastric Solutions, Inc | ESOPHYX (Device) | Food and Beverage | Cash or cash equivalent | $113.43 | General |
| Category: GERD | ||||||
| 05/18/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $99.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/12/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Immunology | ||||||
| 12/08/2017 | Prometheus Laboratories Inc. | — | Food and Beverage | In-kind items and services | $11.73 | General |
| 07/25/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Immunology | ||||||
| 05/23/2017 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Immunology | ||||||
| 03/21/2017 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 808 | 1,127 | $392,323 | $97,738 |
| 2022 | 11 | 627 | 922 | $340,118 | $77,824 |
| 2021 | 12 | 774 | 1,064 | $394,383 | $90,620 |
| 2020 | 13 | 620 | 918 | $286,165 | $70,359 |
Total Patients
2,829
Total Services
4,031
Medicare Billing
$336,541
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 278 | 544 | $87,732 | $34,308 | 39.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 217 | 227 | $67,082 | $23,806 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 119 | $27,674 | $10,848 | 39.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 42 | 42 | $57,773 | $8,452 | 14.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 82 | 84 | $72,045 | $6,589 | 9.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 41 | 41 | $41,483 | $4,248 | 10.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 21 | 21 | $20,946 | $3,974 | 19.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $7,976 | $2,869 | 36.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 27 | $9,611 | $2,642 | 27.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 197 | 426 | $68,032 | $24,815 | 36.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 116 | 124 | $36,828 | $13,016 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 141 | $32,430 | $12,766 | 39.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 86 | 87 | $74,955 | $6,982 | 9.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 21 | 21 | $22,470 | $4,114 | 18.3% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $14,058 | $3,974 | 28.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 26 | 26 | $36,530 | $3,758 | 10.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 27 | 27 | $28,715 | $2,693 | 9.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $15,386 | $2,610 | 17.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $8,544 | $2,248 | 26.3% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $2,169 | $849.31 | 39.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 296 | 554 | $92,197 | $32,420 | 35.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 92 | $21,160 | $9,517 | 45.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 83 | 86 | $25,686 | $9,039 | 35.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 84 | 84 | $73,345 | $6,942 | 9.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 36 | 36 | $50,580 | $6,726 | 13.3% |
About Dr. Asad Rafiq, MD
Dr. Asad Rafiq, MD is a Internal Medicine healthcare provider based in Carol Stream, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1295879666.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Asad Rafiq, MD has received a total of $1,271 in payments from pharmaceutical and medical device companies, with $221.28 received in 2024. These payments were reported across 43 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,051).
As a Medicare-enrolled provider, Rafiq has provided services to 2,829 Medicare beneficiaries, totaling 4,031 services with total Medicare billing of $336,541. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Carol Stream, IL
- Active Since 02/17/2007
- Last Updated 03/26/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1295879666
Products in Payments
- ESOPHYX (Device) $338.28
- STELARA (Biological) $331.19
- SUPREP BOWEL PREP (Drug) $106.64
- VOQUEZNA (Drug) $103.25
- TRULANCE (Drug) $99.80
- SUTAB (Drug) $73.31
- REMICADE (Biological) $54.57
- Cimzia (Drug) $41.87
- REZDIFFRA (Drug) $39.56
- TREMFYA (Drug) $21.78
- ENTYVIO (Biological) $21.69
- DIFICID (Drug) $13.87
- Humira (Biological) $13.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Carol Stream
Nausheen Hasan, M.d, M.D
Internal Medicine — Payments: $10,761
Internal Medicine $10,761
Susan Ignatius, Md, MD
Internal Medicine — Payments: $3,055
Internal Medicine $3,055
Angelo Miele, Md, MD
Internal Medicine — Payments: $1,878
Internal Medicine $1,878
Lawrence Schouten, Md, MD
Internal Medicine — Payments: $1,441
Internal Medicine $1,441
Mark Bednard, Do, DO
Internal Medicine — Payments: $1,380
Internal Medicine $1,380
Evelyn Diaz-Jimenez, M.d, M.D
Internal Medicine — Payments: $437.60
Internal Medicine $437.60